Adults 18 to 20, any sex, with Tobacco Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Self-reported Cigarette Smoking Risk After Shopping in the StoreLabPrimary· There is one visit in this research: This variable is assessed at that visit, within 5 minutes of the experimental manipulation
Respondents answer the following items: "Do you think you will try a cigarette anytime soon?", "Do you think you will try a cigarette anytime in the next year?"; and "If one of your best friends offered you a cigarette, would you smoke it?". Responses are made on a 1 (Definitely not) to 10 (Definitely yes) scale and summed to produce a total smoking risk scale score (range from 3 - 30). Total scale scores are dichotomized: scores of 3 are coded as '0' (no risk) and any score greater than 3 is coded as '1' (at risk). Outcome is proportion at risk of cigarette smoking (number of participants at
Group
Value
95% CI
Status Quo
.59
.45 – .73
Reduced Poster
.52
.38 – .65
No Price
.39
.28 – .51
Self-reported Vaping/ENDS Risk of UsePrimary· There is one visit in this research: This variable is assessed at that visit, within 5 minutes after experimental manipulation
Respondents answer the following items: "Do you think you will try a vaping product anytime soon?", "Do you think you will try a vaping product anytime in the next year?"; and "If one of your best friends offered you a vaping product, would you use it?". Responses are made on a 1 (Definitely not) to 10 (Definitely yes) scale and summed to produce a total vaping risk scale score (range from 3 - 30). Total scale scores are dichotomized: scores of 3 are coded as '0' (no risk) and any score greater than 3 is coded as '1' (at risk). Outcome is proportion at risk of vaping (number of participants at
Group
Value
95% CI
Status Quo
0.55
0.40 – 0.69
Reduced Poster
0.68
0.45 – 0.70
No Price
0.52
0.37 – 0.67
Self-reported Smokeless Tobacco Use RiskPrimary· There is one visit in this research: This variable is assessed at that visit, within 5 minutes of the experimental manipulation
Respondents answer the following items: "Do you think you will use smokeless tobacco anytime soon?", "Do you think you will try smokeless tobacco anytime in the next year?"; and "If one of your best friends offered you smokeless tobacco, would you use it?". Responses are made on a 1 (Definitely not) to 4 (Definitely yes) scale and summed to produce a total smokeless tobacco risk scale score (range from 3 - 30). Total scale scores are dichotomized: scores of 3 are coded as '0' (no risk) and any score greater than 3 is coded as '1' (at risk). Outcome is proportion at risk of smokeless tobacco us
Group
Value
95% CI
Status Quo
0.41
0.28 – 0.54
Reduced Poster
0.30
0.20 – 0.42
No Price
0.23
0.14 – 0.34
Self-reported Cigarillo/Little Cigar *LCC) Use RiskPrimary· There is one visit in this research: This variable is assessed at that visit, within 5 minutes of the experimental manipulation
Respondents answer the following items: "Do you think you will try a cigarillo/little cigar anytime soon?", "Do you think you will try a cigarillo anytime in the next year?"; and "If one of your best friends offered you a cigarillo, would you smoke it?". Responses are made on a 1 (Definitely not) to 4 (Definitely yes) scale and summed to produce a total cigarillo risk scale score (range from 3 - 30). Total scale scores are dichotomized: scores of 3 are coded as '0' (no risk) and any score greater than 3 is coded as '1' (at risk). Outcome is proportion at risk of LCC use (number of participants
Group
Value
95% CI
Status Quo
0.36
0.24 – 0.49
Reduced Poster
0.41
0.29 – 0.54
No Price
0.44
0.31 – 0.58
Sponsor's own description
The overall aim of this research is to experimentally evaluate different, legally-viable approaches to reducing the impact of the point-of-sale (POS) retail environment on adolescent tobacco use risk. This study will be investigating regulations for four classes of tobacco products (cigarettes, e-cigarettes, smokeless tobacco, little cigars/cigarillos). Study 2 and study 3 (out of 3 studies), occurring concurrently, will examine whether changing the number and content of posters on the outside doors at POS reduced adolescents' tobacco use risk.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07162935 — Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
· NA
· recruiting
NCT07132814 — Abuse Liability for Five Modern Oral Nicotine Products
· NA
· recruiting
NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
· Phase 4
· recruiting
NCT06983678 — Neural Correlates and Behavioral Impact of Withdrawal-induced Hyperalgesia Among People Who Smoke With and Without Chron
· NA
· recruiting
NCT06922617 — STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
· NA
· recruiting
Other RAND trials
Trials by the same sponsor.
NCT06048328 — Game Changers for Family Planning Peer Advocacy Program
· Phase 1, PHASE2
· not yet recruiting
NCT07072819 — Pilot of Training on 988 and Narcan
· NA
· completed
NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
· NA
· recruiting
NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
· NA
· recruiting
NCT06827288 — Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by RAND
Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604508.